Anika Therapeutics Inc (NAS:ANIK)
$ 17.35 -0.2 (-1.14%) Market Cap: 254.10 Mil Enterprise Value: 219.27 Mil PE Ratio: 0 PB Ratio: 1.42 GF Score: 70/100

Anika Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 20, 2023 / 04:45PM GMT
Release Date Price: $27.23 (-0.40%)
Mike Matson
Needham & Company - Analyst

Good afternoon. Thanks again, for joining us at the 22nd Annual Needham Healthcare Conference. I'm Mike Matson and I lead the medtech and diagnostics equity research team here at Needham & Company.

Presenting next, we have Anika Therapeutics, Mike -- CFO, Mike Levitz is going to give a presentation and then we're going to hopefully have some time for questions at the end. (Conference Instructions)

So with that, I'll turn it over to Mike.

Mike Levitz
Anika Therapeutics, Inc. - EVP, CFO & Treasurer

Great. Thank you, Mike. Hello everybody. I appreciate your time today. I'm excited to walk you through a little bit about what Anika has been up to, where we're going, and why we're excited about the opportunity in front of us. Please reference the Safe Harbor statements and our publicly disclosed documents.

So this is an exciting time for Anika. Anika has been around for over 30 years now, but has a very significant opportunity in front of us and has been in the midst of a meaningful

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot